Giraffes vs. blue whales vs. dinosaurs: Contest reveals which one builds its nervous system fastest to evade predators Penn In the News Scientific American Giraffes vs. blue whales vs. dinosaurs: Contest reveals which one builds its nervous system fastest to evade predators Douglas H. Smith and Jean-Pierre Dollé of the Perelman School of Medicine compare the speed at which different species of megafauna extend their nerve fibers. Early data suggest vaccine protects against monkeypox, but questions remain Penn In the News Medscape Early data suggest vaccine protects against monkeypox, but questions remain Stuart Isaacs of the Perelman School of Medicine says that the CDC’s findings on the effectiveness of the monkeypox vaccine are encouraging. $50M gift to accelerate Colton Center for Autoimmunity at Penn Medicine Jonathan Epstein, Penn Medicine’s chief scientific officer; Ezekiel Emanuel, vice provost for global initiatives; Dean J. Larry Jameson; Penn President Liz Magill; Judy and Stewart Colton; E. John Wherry, chair of Systems Pharmacology and Translational Therapeutics; and University of Pennsylvania Health System CEO Kevin Mahoney. $50M gift to accelerate Colton Center for Autoimmunity at Penn Medicine The center for autoimmune research brings together star faculty, powering the next generation of autoimmune disease advances. $50 million gift to University of Pennsylvania for autoimmune disease research Penn In the News Forbes $50 million gift to University of Pennsylvania for autoimmune disease research A $50 million gift from Wharton School alumni Judy and Stewart Colton will further develop the work of the Colton Center for Autoimmunity at the Perelman School of Medicine, with a statement from President Liz Magill. $50 million gift to Penn is aimed at new treatments for autoimmune disease Penn In the News Philadelphia Inquirer $50 million gift to Penn is aimed at new treatments for autoimmune disease E. John Wherry of the Perelman School of Medicine hopes to find better answers for autoimmune conditions as director of the Colton Center for Autoimmunity, established and now accelerated by alumni Judy and Stewart Colton. Penn Medicine teams with Independence Blue Cross on primary care venture Penn In the News Philadelphia Inquirer Penn Medicine teams with Independence Blue Cross on primary care venture Penn Medicine is investing in Independence Blue Cross subsidiary Tandigm Health and adding primary care doctors to Tandigm’s systems, with a statement from CEO Kevin Mahoney. FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults Penn In the News Tallahassee Democrat FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults José Bauermeister of the School of Nursing will assist a Florida State University team in developing research on HIV clinics to decrease infection rates among young gay men. Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
Early data suggest vaccine protects against monkeypox, but questions remain Penn In the News Medscape Early data suggest vaccine protects against monkeypox, but questions remain Stuart Isaacs of the Perelman School of Medicine says that the CDC’s findings on the effectiveness of the monkeypox vaccine are encouraging. $50M gift to accelerate Colton Center for Autoimmunity at Penn Medicine Jonathan Epstein, Penn Medicine’s chief scientific officer; Ezekiel Emanuel, vice provost for global initiatives; Dean J. Larry Jameson; Penn President Liz Magill; Judy and Stewart Colton; E. John Wherry, chair of Systems Pharmacology and Translational Therapeutics; and University of Pennsylvania Health System CEO Kevin Mahoney. $50M gift to accelerate Colton Center for Autoimmunity at Penn Medicine The center for autoimmune research brings together star faculty, powering the next generation of autoimmune disease advances. $50 million gift to University of Pennsylvania for autoimmune disease research Penn In the News Forbes $50 million gift to University of Pennsylvania for autoimmune disease research A $50 million gift from Wharton School alumni Judy and Stewart Colton will further develop the work of the Colton Center for Autoimmunity at the Perelman School of Medicine, with a statement from President Liz Magill. $50 million gift to Penn is aimed at new treatments for autoimmune disease Penn In the News Philadelphia Inquirer $50 million gift to Penn is aimed at new treatments for autoimmune disease E. John Wherry of the Perelman School of Medicine hopes to find better answers for autoimmune conditions as director of the Colton Center for Autoimmunity, established and now accelerated by alumni Judy and Stewart Colton. Penn Medicine teams with Independence Blue Cross on primary care venture Penn In the News Philadelphia Inquirer Penn Medicine teams with Independence Blue Cross on primary care venture Penn Medicine is investing in Independence Blue Cross subsidiary Tandigm Health and adding primary care doctors to Tandigm’s systems, with a statement from CEO Kevin Mahoney. FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults Penn In the News Tallahassee Democrat FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults José Bauermeister of the School of Nursing will assist a Florida State University team in developing research on HIV clinics to decrease infection rates among young gay men. Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
$50M gift to accelerate Colton Center for Autoimmunity at Penn Medicine Jonathan Epstein, Penn Medicine’s chief scientific officer; Ezekiel Emanuel, vice provost for global initiatives; Dean J. Larry Jameson; Penn President Liz Magill; Judy and Stewart Colton; E. John Wherry, chair of Systems Pharmacology and Translational Therapeutics; and University of Pennsylvania Health System CEO Kevin Mahoney. $50M gift to accelerate Colton Center for Autoimmunity at Penn Medicine The center for autoimmune research brings together star faculty, powering the next generation of autoimmune disease advances.
$50 million gift to University of Pennsylvania for autoimmune disease research Penn In the News Forbes $50 million gift to University of Pennsylvania for autoimmune disease research A $50 million gift from Wharton School alumni Judy and Stewart Colton will further develop the work of the Colton Center for Autoimmunity at the Perelman School of Medicine, with a statement from President Liz Magill. $50 million gift to Penn is aimed at new treatments for autoimmune disease Penn In the News Philadelphia Inquirer $50 million gift to Penn is aimed at new treatments for autoimmune disease E. John Wherry of the Perelman School of Medicine hopes to find better answers for autoimmune conditions as director of the Colton Center for Autoimmunity, established and now accelerated by alumni Judy and Stewart Colton. Penn Medicine teams with Independence Blue Cross on primary care venture Penn In the News Philadelphia Inquirer Penn Medicine teams with Independence Blue Cross on primary care venture Penn Medicine is investing in Independence Blue Cross subsidiary Tandigm Health and adding primary care doctors to Tandigm’s systems, with a statement from CEO Kevin Mahoney. FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults Penn In the News Tallahassee Democrat FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults José Bauermeister of the School of Nursing will assist a Florida State University team in developing research on HIV clinics to decrease infection rates among young gay men. Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
$50 million gift to Penn is aimed at new treatments for autoimmune disease Penn In the News Philadelphia Inquirer $50 million gift to Penn is aimed at new treatments for autoimmune disease E. John Wherry of the Perelman School of Medicine hopes to find better answers for autoimmune conditions as director of the Colton Center for Autoimmunity, established and now accelerated by alumni Judy and Stewart Colton. Penn Medicine teams with Independence Blue Cross on primary care venture Penn In the News Philadelphia Inquirer Penn Medicine teams with Independence Blue Cross on primary care venture Penn Medicine is investing in Independence Blue Cross subsidiary Tandigm Health and adding primary care doctors to Tandigm’s systems, with a statement from CEO Kevin Mahoney. FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults Penn In the News Tallahassee Democrat FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults José Bauermeister of the School of Nursing will assist a Florida State University team in developing research on HIV clinics to decrease infection rates among young gay men. Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
Penn Medicine teams with Independence Blue Cross on primary care venture Penn In the News Philadelphia Inquirer Penn Medicine teams with Independence Blue Cross on primary care venture Penn Medicine is investing in Independence Blue Cross subsidiary Tandigm Health and adding primary care doctors to Tandigm’s systems, with a statement from CEO Kevin Mahoney. FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults Penn In the News Tallahassee Democrat FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults José Bauermeister of the School of Nursing will assist a Florida State University team in developing research on HIV clinics to decrease infection rates among young gay men. Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults Penn In the News Tallahassee Democrat FSU awarded grant for ‘mystery shopper’ research to reduce HIV infections in young adults José Bauermeister of the School of Nursing will assist a Florida State University team in developing research on HIV clinics to decrease infection rates among young gay men. Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Penn In the News NPR Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11 Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters. Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
Armored CAR T cells break through immune suppression in solid tumors Penn In the News The Scientist Armored CAR T cells break through immune suppression in solid tumors A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer. New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss. Load More
New treatment target could counter bone loss Penn In the News SciTechDaily New treatment target could counter bone loss A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss.